ABIVAX SA (ABVX)
ABIVAX SA Statistics
Share Statistics
ABIVAX SA has 63.42M shares outstanding. The number of shares has increased by 0.74% in one year.
| Shares Outstanding | 63.42M |
| Shares Change (YoY) | 0.74% |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | 69.34% |
| Shares Floating | 55.16M |
| Failed to Deliver (FTD) Shares | 5.03K |
| FTD / Avg. Volume | 2.35% |
Short Selling Information
The latest short interest is -, so null% of the outstanding shares have been sold short.
| Short Interest | - |
| Short % of Shares Out | null% |
| Short % of Float | null% |
| Short Ratio (days to cover) | null |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -2.29. ABIVAX SA's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -2.29 |
| PS Ratio | 0 |
| Forward PS | 0.9 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for ABIVAX SA.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 2.4.
| Current Ratio | 1.84 |
| Quick Ratio | 1.84 |
| Debt / Equity | 2.4 |
| Debt / EBITDA | -0.73 |
| Debt / FCF | -0.63 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $66.97K |
| Profits Per Employee | $-2.14M |
| Employee Count | 69 |
| Asset Turnover | null |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.49M |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -57.25% in the last 52 weeks. The beta is 1.56, so ABIVAX SA's price volatility has been higher than the market average.
| Beta | 1.56 |
| 52-Week Price Change | -57.25% |
| 50-Day Moving Average | 6.72 |
| 200-Day Moving Average | 9.12 |
| Relative Strength Index (RSI) | 52.21 |
| Average Volume (20 Days) | 214.17K |
Income Statement
In the last 12 months, ABIVAX SA had revenue of 4.62M and earned -147.74M in profits. Earnings per share was -3.43.
| Revenue | 4.62M |
| Gross Profit | 3.91M |
| Operating Income | -127.38M |
| Net Income | -147.74M |
| EBITDA | -133.21M |
| EBIT | -133.91M |
| Earnings Per Share (EPS) | -3.43 |
Balance Sheet
The company has 144.22M in cash and 97.36M in debt, giving a net cash position of 46.86M.
| Cash & Cash Equivalents | 144.22M |
| Total Debt | 97.36M |
| Net Cash | 46.86M |
| Retained Earnings | -438.88M |
| Total Assets | 327.06M |
| Working Capital | 215.93M |
Cash Flow
In the last 12 months, operating cash flow was -154.07M and capital expenditures -643K, giving a free cash flow of -154.72M.
| Operating Cash Flow | -154.07M |
| Capital Expenditures | -643K |
| Free Cash Flow | -154.72M |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | -2756.46% |
| FCF Margin | -3348.08% |
Dividends & Yields
ABVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ABVX is $42.5, which is 557.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $42.5 |
| Price Target Difference | 557.9% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Scores
| Altman Z-Score | -0.59 |
| Piotroski F-Score | 2 |